Efficacy and tolerability of exenatide monotherapy in obese patients with newly diagnosed type 2 diabetes: a randomized, 26 weeks metformin-controlled, parallel-group study. [electronic resource]
Producer: 20130213Description: 2677-81 p. digitalISSN:- 2542-5641
- Adult
- Diabetes Mellitus, Type 2 -- blood
- Exenatide
- Female
- Glycated Hemoglobin -- metabolism
- Humans
- Hypoglycemia -- chemically induced
- Hypoglycemic Agents -- adverse effects
- Insulin Resistance
- Male
- Metformin -- adverse effects
- Middle Aged
- Nausea -- chemically induced
- Obesity -- blood
- Peptides -- adverse effects
- Venoms -- adverse effects
- Weight Loss -- drug effects
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.